Fa-Jun Qu

Publications (3)2.59 Total impact

• Article: Holmium laser versus conventional transurethral resection of the bladder tumor.

  Jing-Fei Teng, Kai Wang, Lei Yin, Fa-Jun Qu, Dong-Xu Zhang, Xin-Gang Cui, Dan-Feng Xu
  [show abstract] [hide abstract]
  ABSTRACT: Transurethral resection of the bladder tumor (TURBT) remains the gold standard for non-muscle-invasive bladder cancer (NMIBC). Laser techniques have been widely used in urology. This analysis aimed to assess the safety and efficacy of holmium resection of the bladder tumor (HoLRBT) vs. TURBT. A systemic search of MEDLINE, Embase, Web of Science, and The Cochrane Library as well as manual bibliography searches were performed to identify the relevant studies. The pooled estimates of operation time, obturator nerve reflex rate, bladder perforation rate, bladder irrigation rate, catheterization time, hospital stay, and one- and two-year recurrence free survivals were calculated. Five studies were enrolled into our meta-analysis. No significant difference was observed in the operation time between groups (weighted mean difference (WMD) 1.01, 95% confidential interval (95%CI) -3.52 - 5.54, P = 0.66). The significant difference in the obturator nerve reflex (OR 0.05, 95%CI 0.01 - 0.04, P = 0.004), bladder perforation (OR 0.14, 95%CI 0.03 - 0.61, P = 0.009), bladder irrigation (OR 0.13, 95%CI 0.04 - 0.45, P = 0.001), catheterization time (WMD -0.96, 95%CI -1.11 to -0.82, P < 0.00001), and hospital stay (WMD -1.46, 95%CI -1.65 to -1.27, P < 0.00001) showed advantages of HoLRBT over TURBT. The 2-year recurrence free survival rate favors the HoLRBT group (OR 1.46, 95%CI 1.02 - 2.11, P = 0.04). As a promising technique, HoLRBT is safe and efficient, and showed several advantages over TURBT. HoLRBT can be used as an alternative procedure for TURBT in terms of low-grade papillary urothelial carcinoma or low-grade early TNM-stage urothelial carcinoma.
  Chinese medical journal 05/2013; 126(9):1761-5. · 0.86 Impact Factor
• Article: A complex urinary fistula after Bricker ileal conduit.

  Fa-Jun Qu, Jing-Fei Teng, Xin-Gang Cui, Yi Gao, Lei Yin, Yu-Shan Liu, Ya-Cheng Yao, Dan-Feng Xu
  Chinese medical journal 04/2013; 126(7):1246. · 0.86 Impact Factor
• Article: Evaluating the oncologic outcomes in 152 patients undergoing extraperitoneal laparoscopic radical prostatectomy.

  Xun-Gang Li, Dong-Xu Zhang, Xin-Gang Cui, Dan-Feng Xu, Yi Hong, Yao Li, Yi Gao, Yu-Shan Liu, Lei Yin, Fa-Jun Qu, Jun-Kai Wang, Ming Chen, Jie Chen, Lu Chen, Kai Wang
  [show abstract] [hide abstract]
  ABSTRACT: Although many midterm oncologic data have been reported for extraperitoneal laparoscopic radical prostatectomy (ELRP) in western countries, few oncologic data of the extraperitoneal procedure was published in China. The aim of the study was to evaluate the oncologic outcomes of patients treated with ELRP in China. From January 2005 to March 2010, a total of 152 consecutive patients diagnosed with clinically localized prostate cancer were included in this study and treated with ELRP. The patients were staged according to the TNM (tumor, nodes, metastases) system. Median and mean postoperative follow-up were 28.1 months and 27.0 months, respectively. The patients were retrospectively analyzed for progression-free survival. One hundred and twelve cases (73.7%) were postoperatively diagnosed as pT2 in, and 40 cases (26.3%) as pT3. Positive lymph nodes were shown in 5 patients (3.3%). Gleason score was < 7 in 49 men (32.2%), 7 in 69 men (45.4%), and > 7 in 34 men (22.4%). Positive surgical margins (PSM) were observed in 15 patients (9.9%), which included 32.0% of all pT3a cases and 46.7% of all pT3b cases, respectively. The overall prostate-specific antigen recurrence-free survival rate was 86% in all patients. The recurrence-free survival rates were 91.8% and 62.2% in pT2N0 patients and pT3N0 patients, respectively. Preoperative prostate-specific antigen, surgical margins, tumor stage, and lymph nodal status were identified as independent predictors of biochemical recurrence-free survival using multivariate Cox proportional hazard model. ELRP is a precise, safe and effective procedure at this particular Chinese institution. The prognostic power of prostate-specific antigen relapse after ELRP is not identical to that described previously with transperitoneal or open retropubic approaches.
  Chinese medical journal 05/2012; 125(9):1529-35. · 0.86 Impact Factor